408 related articles for article (PubMed ID: 8529093)
1. Regulation of transcription functions of the p53 tumor suppressor by the mdm-2 oncogene.
Chen J; Lin J; Levine AJ
Mol Med; 1995 Jan; 1(2):142-52. PubMed ID: 8529093
[TBL] [Abstract][Full Text] [Related]
2. The tumor suppressor p53 and the oncoprotein simian virus 40 T antigen bind to overlapping domains on the MDM2 protein.
Brown DR; Deb S; Muñoz RM; Subler MA; Deb SP
Mol Cell Biol; 1993 Nov; 13(11):6849-57. PubMed ID: 8413278
[TBL] [Abstract][Full Text] [Related]
3. Increased mdm-2 expression in a p53-independent manner blocks UV-induced cell cycle arrest and apoptosis in human osteosarcoma cells.
Dong YB; Yang HL; Elliott MJ; McMasters KM
Tumour Biol; 2003; 24(3):130-9. PubMed ID: 14610316
[TBL] [Abstract][Full Text] [Related]
4. Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein.
Lin J; Chen J; Elenbaas B; Levine AJ
Genes Dev; 1994 May; 8(10):1235-46. PubMed ID: 7926727
[TBL] [Abstract][Full Text] [Related]
5. mdm-2 inhibits the G1 arrest and apoptosis functions of the p53 tumor suppressor protein.
Chen J; Wu X; Lin J; Levine AJ
Mol Cell Biol; 1996 May; 16(5):2445-52. PubMed ID: 8628312
[TBL] [Abstract][Full Text] [Related]
6. Mdm-2 phosphorylation by DNA-dependent protein kinase prevents interaction with p53.
Mayo LD; Turchi JJ; Berberich SJ
Cancer Res; 1997 Nov; 57(22):5013-6. PubMed ID: 9371494
[TBL] [Abstract][Full Text] [Related]
7. The p53-mdm-2 autoregulatory feedback loop.
Wu X; Bayle JH; Olson D; Levine AJ
Genes Dev; 1993 Jul; 7(7A):1126-32. PubMed ID: 8319905
[TBL] [Abstract][Full Text] [Related]
8. The mdm-2 gene is induced in response to UV light in a p53-dependent manner.
Perry ME; Piette J; Zawadzki JA; Harvey D; Levine AJ
Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11623-7. PubMed ID: 8265599
[TBL] [Abstract][Full Text] [Related]
9. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation.
Momand J; Zambetti GP; Olson DC; George D; Levine AJ
Cell; 1992 Jun; 69(7):1237-45. PubMed ID: 1535557
[TBL] [Abstract][Full Text] [Related]
10. Tolerance of high levels of wild-type p53 in transformed epithelial cells dependent on auto-regulation by mdm-2.
Blaydes JP; Gire V; Rowson JM; Wynford-Thomas D
Oncogene; 1997 Apr; 14(15):1859-68. PubMed ID: 9150392
[TBL] [Abstract][Full Text] [Related]
11. Physical and functional interactions between PML and MDM2.
Wei X; Yu ZK; Ramalingam A; Grossman SR; Yu JH; Bloch DB; Maki CG
J Biol Chem; 2003 Aug; 278(31):29288-97. PubMed ID: 12759344
[TBL] [Abstract][Full Text] [Related]
12. Mapping of the p53 and mdm-2 interaction domains.
Chen J; Marechal V; Levine AJ
Mol Cell Biol; 1993 Jul; 13(7):4107-14. PubMed ID: 7686617
[TBL] [Abstract][Full Text] [Related]
13. Physical and functional interaction between wild-type p53 and mdm2 proteins.
Haines DS; Landers JE; Engle LJ; George DL
Mol Cell Biol; 1994 Feb; 14(2):1171-8. PubMed ID: 8289798
[TBL] [Abstract][Full Text] [Related]
14. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene.
Miyashita T; Reed JC
Cell; 1995 Jan; 80(2):293-9. PubMed ID: 7834749
[TBL] [Abstract][Full Text] [Related]
15. mdm-2 expression correlates with wild-type p53 status in esophageal adenocarcinoma.
Soslow RA; Altorki NK; Yang G; Xie D; Yang CS
Mod Pathol; 1999 Jun; 12(6):580-6. PubMed ID: 10392633
[TBL] [Abstract][Full Text] [Related]
16. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
[TBL] [Abstract][Full Text] [Related]
17. Regulation of transcription of the human presenilin-1 gene by ets transcription factors and the p53 protooncogene.
Pastorcic M; Das HK
J Biol Chem; 2000 Nov; 275(45):34938-45. PubMed ID: 10942770
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of Mdm2 and MdmX fusion proteins alters p53 mediated transactivation, ubiquitination, and degradation.
Ghosh M; Huang K; Berberich SJ
Biochemistry; 2003 Mar; 42(8):2291-9. PubMed ID: 12600196
[TBL] [Abstract][Full Text] [Related]
19. The mdm-2 oncogene can overcome wild-type p53 suppression of transformed cell growth.
Finlay CA
Mol Cell Biol; 1993 Jan; 13(1):301-6. PubMed ID: 8417333
[TBL] [Abstract][Full Text] [Related]
20. The LAZ3/BCL6 oncogene encodes a sequence-specific transcriptional inhibitor: a novel function for the BTB/POZ domain as an autonomous repressing domain.
Deweindt C; Albagli O; Bernardin F; Dhordain P; Quief S; Lantoine D; Kerckaert JP; Leprince D
Cell Growth Differ; 1995 Dec; 6(12):1495-503. PubMed ID: 9019154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]